Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 02, 2026 1.123
October 01, 2026 0.9993
September 30, 2026 1.011
September 29, 2026 0.9935
September 28, 2026 0.9926
September 25, 2026 0.9859
September 24, 2026 0.9911
September 23, 2026 0.988
September 22, 2026 0.9935
September 21, 2026 0.9781
September 18, 2026 0.9633
September 17, 2026 0.9746
September 16, 2026 0.9625
September 15, 2026 0.9572
September 14, 2026 0.9285
September 11, 2026 0.8941
September 10, 2026 0.8746
September 09, 2026 0.8738
September 08, 2026 0.8932
September 04, 2026 0.908
September 03, 2026 0.9036
September 02, 2026 0.9196
September 01, 2026 0.9149
August 31, 2026 0.9462
August 28, 2026 0.9549
Date Value
August 27, 2026 0.974
August 26, 2026 0.9729
August 25, 2026 0.9625
August 24, 2026 0.9529
August 21, 2026 1.084
August 20, 2026 1.058
August 19, 2026 1.032
August 18, 2026 0.9558
August 17, 2026 0.9732
August 14, 2026 0.9674
August 13, 2026 0.9827
August 12, 2026 0.9717
August 11, 2026 0.9677
August 10, 2026 0.9659
August 07, 2026 0.9285
August 06, 2026 0.8909
August 05, 2026 0.9222
August 04, 2026 0.8732
August 03, 2026 0.8659
July 31, 2026 0.8152
July 30, 2026 0.8346
July 29, 2026 0.8196
July 28, 2026 0.8384
July 27, 2026 0.7976
July 24, 2026 0.7932

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Lifecore Biomedical, Inc. --
Repligen Corp. 4.854
Bio-Techne Corp. 5.361
Codexis, Inc. 3.771
MetaStat, Inc. --

Price to Book Value Related Metrics

PS Ratio 2.892
PEG Ratio -1.822
Price to Free Cash Flow 179.68
Price 38.75
Earnings Yield -6.88%
Market Cap 1.696B
PEGY Ratio -1.822